DR. ALESSANDRO DI ROCCO, MD
Neurology at 32 St, New York, NY

License number
New York 198036
Category
Neurology
Type
Neurology
Address
Address
145 E 32Nd St FLOOR 2ND, New York, NY 10016
Phone
(212) 263-4838
(212) 263-4837 (Fax)

Personal information

See more information about ALESSANDRO DI ROCCO at radaris.com
Name
Address
Phone
Alessandro Di Rocco
New York, NY
(212) 877-7333

Organization information

See more information about ALESSANDRO DI ROCCO at bizstanding.com

Alessandro Di Rocco MD

New York, NY

Industry:
Neurologist
Phone:
(212) 263-4838 (Phone)
Addresses:
145 E 32 St, Fl2, New York, NY 10016
650 1 Ave, New York, NY 10016
Alessandro Di Rocco
Categories:
Neurology Physicians & Surgeons

Professional information

Alessandro Alessandro Di Rocco Photo 1

Alessandro Alessandro Di Rocco, New York NY

Specialties:
Neurologist
Address:
145 E 32Nd St, New York, NY 10016
Education:
University of Genoa, Faculty of Medicine and Surgery - Doctor of Medicine
Mount Sinai Hospital, The - Fellowship - Movement Disorders
Mount Sinai Hospital, The - Residency - Neurology
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)


Alessandro Di Rocco Photo 2

Dr. Alessandro Di Rocco, New York NY - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Neurology)
Address:
Parkinsons Mvmnt Disorders Cntr
240 E 38Th St SUITE 20, New York 10016
(212) 263-4838 (Phone)
Certifications:
Neurology, 2004
Awards:
Healthgrades Honor Roll
Languages:
English, Italian
Education:
Medical School
University of Genova / Faculty of Medicine And Surgery
Brookdale Hospital SUNY
Graduated: 1988
Mt Sinai Med Center
Graduated: 1991
Graduated: 1993


Alessandro Rocco Photo 3

Use Of Famotidine And Related Compounds In The Treatment Of Movement Disorders

US Patent:
5496836, Mar 5, 1996
Filed:
May 5, 1994
Appl. No.:
8/238704
Inventors:
Alessandro Di Rocco - New York NY
Susan Molinari - River Edge NJ
Ram Kaminski - Riverdale NY
Assignee:
Mount Sinai School of Medicine of the City University of New York - New York NY
International Classification:
A61K 31425
US Classification:
514370
Abstract:
The present invention relates to methods of treating movement disorders which comprise administering famotidine or a related compound to a subject in need of such treatment, wherein the motor disorder is selected from the group consisting of olivo-ponto-cerebellar atrophy, multi-system atrophy, Shy-Drager syndrome, kernicterus, Leigh's disease, cerebellar ataxias, neonatal hypoxemia syndromes, carbon monoxide poisoning, progressive supranuclear palsy, tardive dystonias, oculogyral crises, manganese poisoning, Wilson's Disease, Huntington's Disease, striatonigral degeneration, ingestion by the subject of phenothiazines, butyrophenones or reserpine, Alzheimer's Disease, normal pressure hydrocephalus, obstructive hydrocephalus, physiologic tremor, benign familial tremor, cerebellar tremor, rubral tremor, toxic tremor, metabolic tremor, senile tremor, chorea, ballism, athetosis, dystonia, tics, tardive dyskinesia, paroxysmal choreoathetosis, tonic spasm, akathisia, muscle rigidity, postural instability, bradykinesia, difficulty in initiating movements, muscle cramps, dyskinesias, myoclonus, and Creutzfeldt-Jacob Disease, and wherein the subject does not exhibit bradyphrenia. In preferred embodiments of the invention, the movement disorder is associated with an abnormality in basal ganglia structure or function. In a particularly preferred embodiment of the invention, the movement disorder is a component of Parkinson's Disease.